Filter
615
Filtered Results: 615
Text search:
Selection
and
rational
use
Featured
Recommendations
75
New Publications
199
Language
Document type
No document type
328
Guidelines
122
Studies & Reports
87
Manuals
37
Strategic & Response Plan
19
Training Material
11
Fact sheets
5
Situation Updates
4
Infographics
1
Online Courses
1
Countries / Regions
India
35
Ethiopia
27
Kenya
22
South Africa
19
Ghana
18
Uganda
18
Global
18
Sierra Leone
17
Nepal
16
Nigeria
15
Western and Central Europe
15
Zambia
14
Liberia
13
Tanzania
11
Namibia
8
Botswana
8
Rwanda
7
Africa
7
Philippines
6
Indonesia
6
Malawi
6
Eastern Europe
6
Congo, Democratic Republic of
5
Cameroon
5
Zimbabwe
5
Eastern Europe and Central Asia
5
Syria
4
Bangladesh
4
Eswatini/ Swaziland
4
Lesotho
4
Latin America and the Carribbean
4
Senegal
3
Haiti
3
Pakistan
3
Iraq
3
Jordan
3
Afghanistan
3
Cambodia
3
Mozambique
3
Ukraine
3
Libya
3
Sri Lanka
3
South–East Asia Region
3
Asia
3
Burkina Faso
2
USA
2
Sudan
2
Myanmar / Burma
2
Laos
2
Qatar
2
Iran
2
Guinea
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Somalia
1
Germany
1
Lebanon
1
Egypt
1
Thailand
1
Gambia
1
Benin
1
Argentina
1
Peru
1
Colombia
1
Honduras
1
El Salvador
1
Bolivia
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Venezuela
1
Palestine
1
Djibouti
1
Congo-Brazzaville
1
Russia
1
Georgia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
282
Clinical Guidelines
41
Public Health
37
Key Resources
23
Women & Child Health
20
Capacity Building
13
Pharmacy & Technologies
13
Annual Report MEDBOX
2
Toolboxes
AMR
99
Pharmacy
57
TB
36
COVID-19
34
Mental Health
19
HIV
18
Caregiver
12
Disability
10
Rapid Response
10
Planetary Health
10
Global Health Education
9
NTDs
7
Conflict
6
NCDs
6
Ebola
5
Polio
3
Refugee
3
Specific Hazards
2
Health Financing Toolbox
2
Cholera
1
Natural Hazards
1
Social Ethics
1
Chapter 16: Managing medicine selection - Key topics: the concept of essential medicines; selection of essential medicines and development of ess...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure fr...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing ... disseminating the Model List of Essential Medicines (Model List). WHO is committed to supporting Member States in sharing best practices in selecting
essential medicines, and in developing processes for the selection of medicines for national essential medicines lists (national EMLs, or NEMLs) consistent with the evidence-based methods used for updating the WHO Model List.
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and...
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available ...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is i...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of maternal and child health services. As part of these efforts, ...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing ...
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic...
Last Mile delivery presents a unique challenge in making health commodities available in the developing world. This guide, designed for in-country practitioners and decisionmakers, uses a range of r...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the ... of blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and its administration to the patient. There is a risk of error in each process in this “transfusion chain” and a failure at any of these stages can have serious implications for the recipients of blood and blood products. Thus, while blood transfusion can be life-saving, there are associated risks, particularly the transmission of bloodborne infections.
Screening for transfusion-transmissible infections (TTIs) to exclude blood donations at risk of transmitting infection from donors to recipients is a critical part of the process of ensuring that transfusion is as safe as possible. Effective screening for evidence of the presence of the most common and dangerous TTIs can reduce the risk of transmission to very low levels.
Screening for transfusion-transmissible infections (TTIs) to exclude blood donations at risk of transmitting infection from donors to recipients is a critical part of the process of ensuring that transfusion is as safe as possible. Effective screening for evidence of the presence of the most common and dangerous TTIs can reduce the risk of transmission to very low levels.
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America ... the Caribbean at the national, subnational, and local level update their knowledge in order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive h...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situa...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable ...
Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. ... use of snake anti-venom can substantially reduce mortality and morbidity due to snakebites. These guidelines are a revised and updated version of Regional Guidelines for the Management of snakebites published by the WHO Regional Office in South-East Asia in 2011. These guidelines aim to promote the rational management of snakebite cases in various health facilities where trained health functionaries and quality snake antivenom are available.
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor...
